baber/WOPTO huggingface dataset:
Patent AT-E136229-T1 (AT)
Inventor: CICILE JEAN-CHARLES
IPC: B01D53/22
Filed: 1991-03-01
Granted: 1996-04-15
Abstract: The gas mixture (GR) first of all undergoes a compression stage (C1) and then a gas permeation (X1) to extract hydrogen. The hydrogen-free gas phase is condensed (E2) at approximately -20 DEG C to recover a methane-rich gas phase (GNS). The condensed phase is then distilled to separate it into a C2 hydrocarbon-rich fraction and a fraction containing C3 and C4 hydrocarbons (LPG). Use for upgrading oil refinery gases. <IMAGE>
Patent AT-E117591-T1 (AT)
Inventor: PATRIER LIONEL
IPC: B01F3/04
Filed: 1991-11-05
Granted: 1995-02-15
Abstract: The apparatus for treatment according to the invention comprises a vessel comprising, in its upper part, a multiplicity of distribution spouts (8) arranged uniformly in a horizontal plane of cross-section of the vessel (1), these distribution spouts (8) consisting of tubes connected to a distribution circuit (5) for the fluid to be treated and provided with a plurality of calibrated orifices (11) and, in its lower part, a multiplicity of recovery drains (13) arranged uniformly in a cross-section plane of the vessel (1), these drains being provided with a plurality of calibrated orifices (15), means for injecting gas (16) are uniformly arranged in a cross-section plane of the vessel which is situated above the recovery drains (13). The invention applies especially to water treatment using ozonisation to produce drinking water. <IMAGE>
Patent AT-E97384-T1 (AT)
Inventor: ROMAND PAUL
IPC: B65G47/91
Filed: 1991-09-10
Granted: 1993-12-15
Abstract: This device comprises a plurality of gripper means (9) each carried by a slide (7) moving in a rail (1) mounted diametrically on the free end of a pulley (5), means (13, 18) being provided for placing the slides (7) and the pulleys (5) in movement independently of one another, as well as other means for controlling them which act on them, also independently of one another, so that they enable the gripper means (9) to be brought into relative positions predetermined as a function of the particular shape of the product which is to be gripped. Applicable particularly to the garment-making industry. <IMAGE>
Patent AT-E163970-T1 (AT)
Inventor: KRAUS MATTHIAS H
IPC: A61K39/395
Filed: 1990-11-30
Granted: 1998-03-15
Abstract: A DNA fragment distinct from the epidermal growth factor receptor (EGFR) and erbB-2 genes was detected by reduced stringency hybridization of v-erbB to normal genomic human DNA. cDNA cloning revealed a predicted 148 kd transmembrane polypeptide with structural features identifying it as a member of the erbB family, prompting designation of the new gene as erbB-3. It was mapped to human chromosome 12q11-13 and was shown to be expressed as a 6.2 kb transcript in a variety of normal tissues of epithelial origin. Markedly elevated erbB-3 mRNA levels were demonstrated in certain human mammary tumor cell lines. These findings indicate that increased erbB-3 expression, as in the case of EGFR and erbB-2, plays a role in some human malignancies. Using erbB-3 specific antibodies (polyclonal or monoclonal), the erbB-3 protein was identified as a 180 kDa glycoprotein, gp180erbB-3. The intrinsic catalytic function of gp180erbB-3 was uncovered by its ability to autophosphorylate in vitro. Ligand-dependent signaling of its cytoplasmic domain was established employing transfectants which express a chimeric EGFR/erbB-3 protein, gp180EGFR/erbB-3. EGF induced tyrosine phosphorylation of the chimera and promoted soft agar colony formation of such transfectants. These findings, combined with the detection of constitutive tyrosine phosphorylation of gp180erbB-3 in 4 out of 12 human mammary tumor cell lines, implicate the activated erbB-3 product in the pathogenesis of some human malignancies. Thus, this invention also relates to procedures for targeting a therapeutic drug to cells having a high level of the receptor protein.
Patent AT-E102038-T1 (AT)
Inventor: WECKER EBERHARD
IPC: A61K/
Filed: 1990-12-11
Granted: 1994-03-15
Abstract: 2-Methyl-1-octadecylglycero-(3)-phosphocholine is suitable for killing mammalian lymphocytes activated by antigens or mitogens.
Patent AT-E153252-T1 (AT)
Inventor: KATZ DANIEL
IPC: A63F9/06
Filed: 1990-11-13
Granted: 1997-06-15
Abstract: A puzzle method and apparatus consisting of a plurality of modules (10) that have first and second surfaces, that are planar, angled or curved, and that have slits (100) in at least two sides of the perimeters of the modules. Portions of the modules (A-D) constitute display surfaces adapted to carry segments of a pattern. The slits (100) of each module may be interlinked with the slits of adjacent modules to form a composite assembly in two or three dimensions that displays a newly created pattern or a predetermined pattern or succession of predetermined patterns on one or both of the first and second surfaces of the composite assembly.
Patent AT-E159476-T1 (AT)
Inventor: JOHNSTONE PETER
IPC: B65B11/28
Filed: 1991-08-08
Granted: 1997-11-15
Abstract: An apparatus for palletising and wrapping a load of material which may be irregularly shaped solid articles; liquid or flowable granules comprising a support base (10, 30) and an open upstanding framework (12, 44) adapted to form a volume to be at least partially filled with articles, wherein said framework (12, 44) provides a formwork for plastic film (41) wrapped there around at least on its vertical periphery.
Patent AT-E127749-T1 (AT)
Inventor: EIERMANN DANKWART
IPC: B64C31/02
Filed: 1992-04-18
Granted: 1995-09-15
Abstract: A propulsion unit for a motorised glider, having a propeller which can be extended on an arm and having a rotary-piston internal-combustion engine which is arranged in the fuselage of the aircraft, having silencers, which are likewise provided in the fuselage, in the induction and exhaust line, and having a heat exchanger for the coolant of the internal-combustion engine on the rear side of the arm, in the cycle of rotation of the propeller. <IMAGE>
Patent AT-E142877-T1 (AT)
Inventor: BIELLA GABRIELE
IPC: A61K31/403
Filed: 1992-05-11
Granted: 1996-10-15
Abstract: The present invention relates to new pharmaceutical compositions comprising therapeutically effective amounts of 2-bromomelatonin for use in the therapy of sleep disorders and in the pre-anaesthetic medication.
Patent AT-E130982-T1 (AT)
Inventor: DIETRICH WERNER DIPL ING
IPC: H03L7/085
Filed: 1992-05-14
Granted: 1995-12-15
Abstract: A digital phase lock loop is specified which comprises an oscillator circuit (1) having an approximately constant output frequency, a frequency divider (2) which can be switched between two dividing factors, a feedback divider (3), a phase detector device (4) and a logic circuit (5) and is distinguished by particular noise immunity and extensive possibilities of use. The phase lock loop is particularly suitable for use in digital information transmission systems for extracting or restoring a clock signal. <IMAGE>
Patent AT-E159636-T1 (AT)
Inventor: TERKOWSKI JUERGEN
IPC: H04M1/00
Filed: 1992-07-11
Granted: 1997-11-15
Abstract: The frequency and mark/space ratio of call progress tones can greatly deviate from the guide lines of the postal administrations, particularly in private branch exchanges. As a result, it is difficult to avoid malfunctions when connecting the subscriber terminals to a communications network. To enable even an untrained user to connect the subscriber terminal to an existing communications system, a device for learning call progress tones is provided in the subscriber terminal according to the invention. For this purpose, the subscriber terminal contains a control which calls up the call progress tones from the communications system and determines their mark/space ratio which is stored in a memory. If the subscriber terminal is connected to a private branch exchange, both the call progress tones of the extension and those outside the extension can be learned. The device can be used in any subscriber terminal which must respond to call progress tones. <IMAGE>
Patent AT-E134759-T1 (AT)
Inventor: WUENNING JOACHIM
IPC: F23D11/02
Filed: 1992-08-06
Granted: 1996-03-15
Abstract: A burner suitable for heating a furnace chamber of an industrial furnace which is equipped with a recuperative preheater for combustion air has a combustion chamber at one end and a feed-through cap at the other end which is accessible outside of a furnace in which the burner is installed. The tubular recuperative preheater is of the coaxial countercurrent flow configuration extending between the combustion chamber and an annular outflow collector cap. A coaxial fuel pipe is centered in the burner extending to the combustion chamber. Overheating of the burner cap is prevented by means of a spacer sleeve of small heat conductivity interposed between the preheater and the burner cap. This permits the valves to be seated in the burner cap without risk of thermal damage. For protection of personnel against contact with hot surfaces, a perforated metal shield is provided between the burner cap and the outflow cap of the recuperator, essentially covering all the portions of the burner outside a furnace wall.
Patent AT-E133465-T1 (AT)
Inventor: ERRANI DEO
IPC: E05B65/00
Filed: 1992-11-24
Granted: 1996-02-15
Abstract: The lock with burglar-proof locking bolt, particularly for safes, comprises a locking bolt (3) slideable between a position in which it engages the selvage (8) in the abutment jamb (9) of the door of the safe and a position in which it engages a seat (7) in the lock stile (1) of the door, the bolt being loosely coupled to a lever (4) which is articulated to a movable element(2) actuated by the lock and which is provided with a tooth (10); mutual contact planes (11,13) are defined in the locking bolt and in the lever and are inclined with respect to the sliding axis of the locking bolt so as to produce, when the locking bolt is forced to retract into the seat, the oscillation of the lever into the position in which the tooth interacts with the edge of the seat. <IMAGE>
Patent AT-E171544-T1 (AT)
Inventor: MOCHNAL DENNIS
IPC: A61K35/18
Filed: 1992-05-14
Granted: 1998-10-15
Abstract: A method for preparing treated naturally occurring or synthetic particles using a blood cell processor is provided. The method comprises adjusting the blood cell processor to allow a dispersion of such particles to come into contact with a treatment material in an amount and for a period of time sufficient to modify all or a portion of the surface of such particles. In a preferred embodiment, the method comprises washing collected red blood cells; separating a selected volume of said washed red blood cells; and treating one portion of said separated washed cells with a selected proteolytic enzyme, to prepare a red blood cell reagent.
Patent AT-E129382-T1 (AT)
Inventor: GIROUD-ABEL BRUNO
IPC: A01C1/00
Filed: 1991-12-09
Granted: 1995-11-15
Abstract: PCT No. PCT/FR91/00984 Sec. 371 Date Oct. 13, 1992 Sec. 102(e) Date Oct. 13, 1992 PCT Filed Dec. 9, 1991 PCT Pub. No. WO92/10087 PCT Pub. Date Jun. 25, 1992.Artificial seeds, characterized in that they consist of: a meristematic tissue, a support in contact with said meristematic tissue, and preferably surrounding said meristematic tissue on all sides, this support being a) a solid substance which is not compact and which comprises, in the air and in the dry state, a ratio by volume of air of at least 10%, preferably at least 50%, b) permeable to gases and/or vapors, preferably air- and steam-permeable, c) dry or dryable, a shell made of polymer material and soluble in water, which surrounds the unit composed of support and meristematic tissue, a water-tight film which covers the inside of the shell of polymer material.
Patent AT-E180908-T1 (AT)
Inventor: ROBINSON SCOTT G
IPC: G06F9/38
Filed: 1992-03-03
Granted: 1999-06-15
Abstract: A system or method is provided for translating a first program code to a second program code and for executing the second program code while preserving instruction state-atomicity of the first code. The first program code is executable on a computer having a first architecture adapted to a first instruction set and the second program code is executable on a computer having a memory and register state and a second architecture adapted to a second instruction set that is reduced relative to the first instruction set. A first computer translates the first code instructions to corresponding second code instructions in accordance with a pattern code that defines first code instructions in terms of second code instructions. The second code instructions for each first code instruction organized in a granular instruction sequence having in order at least two groups, a first group having a first subgroup including second code read instructions and a second subgroup including modify instructions and a second group having a third subgroup including state update instructions subject to exception, including any special write instruction required to implement the first code instruction being translated, and a fourth subgroup including state update instructions free of exception.
Patent AT-E160149-T1 (AT)
Inventor: MASCELLANI GIUSEPPE
IPC: C08B37/00
Filed: 1992-08-06
Granted: 1997-11-15
Abstract: PCT No. PCT/EP92/01790 Sec. 371 Date Feb. 23, 1994 Sec. 102(e) Date Feb. 23, 1994 PCT Filed Aug. 6, 1992 PCT Pub. No. WO93/05074 PCT Pub. Date Mar. 18, 1993A natural dermatan sulphate with antithrombinic activity in excess of 220 U/mg which comprises an oligosaccharide sequence with a high degree of sulfation, having formula (III)    <IMAGE>  (III)n=integers 1 or 2; R4=SO3, or H; R6=H, or SO3; G=glucuronic acid: I-non-sulfated uronic acid, preferably glucuronic acid, is extracted from organs, and subsequently purified in mild operating conditions, at pH 5-7, isolation and fractionation being carried out with macroreticular ion exchange resins, having a particle size of less than 10  mu .
Patent AT-E168398-T1 (AT)
Inventor: CIPOLLI ROBERTO
IPC: C08K5/3477
Filed: 1993-01-05
Granted: 1998-08-15
Abstract: Self-extinguishing polymeric compositions endowed with high self-extinguishing characteristics when exposed to a flame, based on thermoplastic polymers endowed with elastomeric properties, in particular olefinic polymers or copolymers, comprising:   (a) from 90 to 40 parts by weight of a thermoplastic polymer, or a polymer with elastomeric properties; (b) from 10 to 60 parts by weight of one or more derivatives of 2,4-diamino-1,3,5-triazinyl-6-phosphonic acid having the general formula (I): <CHEM>   o
Patent AT-E121784-T1 (AT)
Inventor: NIWA MINEO
IPC: C12N1/21
Filed: 1993-02-19
Granted: 1995-05-15
Abstract: A mutant cephalosporin C acylase ("CC acylase") of the formula (as its precursor before processing the said precursor form into  alpha -subunit and  beta -subunit thereof in a host cell): A<1><-><2><6><8>-X<1>-Tyr-X<2>-A<2><7><2><-><3><0><4>-X<3>-A<3><0><6>< -><7><7><3 > wherein A<1><-><2><6><8> is the same amino acid sequence as that from Thr<1> to Gly<2><6><8> of native CC acylase, A<2><7><2><-><3><0><4> is the same amino acid sequence as that from Gln<2><7><2> to Tyr<3><0><4> of native CC acylase, A<3><0><6><-><7><7><3> is the same amino acid sequence as that from Val<3><0><6> to Ala<7><7><3> of native CC acylase,     X<1> is Met or other amino acid,     X<2> is Ala or other amino acid and     X<3> is Cys or other amino acid,     providing that when X<1> is Met and X<2> is Ala,     X<3> is an amino acid other than Cys. A DNA coding for the CC acylase is also provided, together with an expression vector containing the said DNA and a microorganism transformed with the said expression vector. The CC acylase is produced by culturing the said transformed microorganism in an aqueous nutrient medium.
Patent AT-E155700-T1 (AT)
Inventor: LEYAT JEAN-CLAUDE
IPC: B01D24/16
Filed: 1993-02-10
Granted: 1997-08-15
Abstract: PCT No. PCT/CH93/00034 Sec. 371 Date Sep. 30, 1993 Sec. 102(e) Date Sep. 30, 1993 PCT Filed Feb. 10, 1993 PCT Pub. No. WO93/15821 PCT Pub. Date Aug. 19, 1993.A liquid filtration apparatus comprises a filter body (1) housing a filter module (3) and having an inlet port (6) for the liquid to be filtered and an outlet port (10) for the filtered liquid. The filter module (3) consists of a compact mass of substantially parallel elongate fibers (28) oriented axially in a cylindrical casing. An inflatable band surrounds the fiber mass and is located between the fiber mass and the inner wall of the cylindrical casing.
Patent AT-E169676-T1 (AT)
Inventor: KINET JEAN PIERRE
IPC: C12N15/09
Filed: 1993-04-16
Granted: 1998-08-15
Abstract: The present invention relates to nucleic acid sequences, encoding amino acid sequences of the alpha, beta, and gamma subunits of the high affinity receptor for immunoglobulin E, and for amino acid sequences of the subunits. The invention further relates to a method of producing the receptor by expressing cDNA for its alpha, beta, and gamma subunits in a host cell simultaneously. Aspects of the invention are methods and compositions to inhibit the function of the human beta subunit, thereby treating or preventing allergic reactions.
Patent AT-E186813-T1 (AT)
Inventor: CHAHROUDI DAY
IPC: E04B1/76
Filed: 1993-05-25
Granted: 1999-12-15
Abstract: A building including high efficiency transparent insulation and optical shutter solar collector (HETIOSSC) to effectively control heat loss and gain in a passively-solar climate control system. HETIOSSC includes a layer of protective glazing, a transparent insulation, an optical shutter, an optional solar radiation absorbing material and optional heat storage elements. When the building and its heat storage are too warm, the optical shutter layer becomes opaque to prevent overheating. During cloudy and cold winter days, HETIOSSC still has a solar transmission and insulation efficiency great enough to collect sufficient sunlight for heating. Location of HETIOSSC on the roof, rather than the walls, does not alter shape and orientation of a building.
Patent AT-E250469-T1 (AT)
Inventor: JONES IAN THOMAS NISBET
IPC: B05D3/02
Filed: 1993-07-06
Granted: 2003-10-15
Abstract: PCT No. PCT/GB93/01418 Sec. 371 Date Mar. 1, 1995 Sec. 102(e) Date Mar. 1, 1995 PCT Filed Jul. 6, 1993 PCT Pub. No. WO94/01224 PCT Pub. Date Jan. 20, 1994A process for coating a metal substrate for packaging end use by applying to a primary substrate a thermosettable composition which is free of added solvent and has a residual solvent content not exceeding 10% derived from the manufacture of any of the ingredients. The composition is applied as a thermosettable film by extrusion in melt (including plastified) form through an extrusion coating die onto a substrate. There is relative movement between the die and the substrate so that successive areas on the substrate are coated with the thermosettable composition, so as to form a film. The primary substrate is the metal substrate for packaging end use or an intermediate temporary support from which the applied coating is transferred onto the metal substrate for packaging end use. The applied coating is thermally cured after extrusion through the extrusion coating die. Compositions suitable for use in this and other coating processes are described.
Patent AT-E178729-T1 (AT)
Inventor: ZWAHLEN FRITZ
IPC: G07D9/00
Filed: 1994-07-21
Granted: 1999-04-15
Abstract: A cash safe (1) has a banknote input/output unit (10) for cashiers operating on both sides. A banknote storage unit (35) is arranged in the armoured safe base unit (15). The banknotes to be dispensed from the safe base unit (15) are supplied in a dispensing unit (11) of the banknote input/output unit (10) in such a way that they can only ever be extracted by one of the two cashiers. The banknote input/output unit (10) can be removed as a whole, undismantled, from the safe base unit (15), even then unauthorised access to the banknotes deposited in the banknote storage unit (15) being impossible. The cash safe (1), on account of its modularity, has high serviceability which is increased, in particular, by simple releasable connections for covering or partitioning panels (83a, 83b) standing vertically one on the other, by the banknote storage unit (35) extendable out of the safe base unit (15) and by a fastening means (9) for relieving tension on cable bundles (115). <IMAGE>
Patent AT-E169266-T1 (AT)
Inventor: LEUTHEUSSER BERNHARD DIPL-KFM
IPC: B29C53/56
Filed: 1994-10-18
Granted: 1998-08-15
Abstract: In a process for mfg. glass fibre reinforcing discs for grinding and cutting discs glass fibre (10) is continuously wound around winding points (4) until a disc (13) is completed. The disc (13) is then transferred by a non-active buffer station (6) to a pressing (7) and a demoulding (8) station. Adjacent discs (13) wound in previous or following cycles are connected to each other by the continuous fibre (10) at a contacting point and the fibre (10) remains uncut until during or after the pressing station (7). Claimed process equipment comprises a rotating round table (2) with winding (5), buffer (6), pressing (7) and demoulding (8) stations. Each station has a circular area (3) formed by winding pins (4). A winding head (9) is positioned above the winding station (5), an axially movable punch (11) above the pressing station (7) and a disc extractor at the demoulding station (8). Also claimed is the appts. used.
Patent AT-E253100-T1 (AT)
Inventor: OLIVIER ERROL J
IPC: C10N20/04
Filed: 1994-07-29
Granted: 2003-11-15
Abstract: A polymer blend is produced by simultaneously blending and shearing a low ethylene content ethylene-propylene polymer and a higher ethylene content ethylene-propylene polymer to reduce their molecular weights and molecular weight distributions and to yield a product than can be recovered as a solid using conventional plastics processing equipment. The sheared blend of polymers can function as a shear stable viscosity index improver with improved low temperature properties.
Patent AT-E167062-T1 (AT)
Inventor: NOELLE RANDOLPH J
IPC: A61K39/395
Filed: 1994-09-02
Granted: 1998-06-15
Abstract: Methods for inducing antigen-specific T cell tolerance are disclosed. The methods involve contacting a T cell with: 1) a cell which presents antigen to the T cell, wherein a ligand on the cell interacts with a receptor on the surface of the T cell which mediates contact-dependent helper effector function; and 2) an antagonist of the receptor on the surface of the T cell which inhibits interaction of the ligand on the antigen presenting cell with the receptor on the T cell. In a preferred embodiment, the cell which presents antigen to the T cell is a B cell and the receptor on the surface of the T cell which mediates contact-dependent helper effector function is gp39. Preferably, the antagonist is an anti-gp39 antibody or a soluble gp39 ligand (e.g., soluble CD40). The methods of the invention can be used to induce T cell tolerance to a soluble antigen or to an allogeneic cell. The methods of the invention can also be used to induce tolerance in cases of bone marrow transplantation and other organ transplants and to inhibit graft-versus-host disease.
Patent AT-E224895-T1 (AT)
Inventor: BAXTER ELLEN W
IPC: A61K31/435
Filed: 1994-10-11
Granted: 2002-10-15
Abstract: Compounds represented by the general formula I:   iseases of the central nervous system.
Patent AT-E183719-T1 (AT)
Inventor: WEILAND JOSEF
IPC: B66C23/34
Filed: 1995-03-11
Granted: 1999-09-15
Abstract: The erection device has a hydraulically operated work cylinder (5). A length-adjustable support (4) is mounted parallel to the work cylinder. It is adaptable to the lifting height of the cylinder and forms a combination unit attached to both the vertical column (2) and the supporting base frame (1) of the crane. The work cylinder combined with the support can be connected to the column and frame by connecting bolts. The support (4) comprises an outer supporting tube and an inner displaceable supporting tube. An adjustment nut guided inside the outer tube has axially an inner thread and radially a full-length oblong hole for holding a push-in bolt. <IMAGE>